Inactive Instrument

Analyst Reco. BioAlliance Pharma SA Euronext Paris

Equities

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

2023	Valerio Therapeutics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	Onxeo SA has Changed its Name to Valerio Therapeutics	CI

Onxeo : Bryan Garnier & Co initiates the coverage of Onxeo with a “Buy” recommendation	20-05-29	PU
Bryan Garnier & Co Initiates Coverage of Onxeo with a “Buy” Recommendation	20-05-27	GL
Onxeo : Bryan Garnier & Co Initiates the Coverage of Onxeo with a “Buy” Recommendation	20-05-27	BU

No results for this search